Jaguar Health, Inc.
JAGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39,034 | -$41,870 | -$49,075 | -$52,600 |
| Dep. & Amort. | $2,358 | $2,388 | $2,292 | $1,813 |
| Deferred Tax | $0 | $0 | $0 | $4,389 |
| Stock-Based Comp. | $1,641 | $2,112 | $3,318 | $3,974 |
| Change in WC | -$3,010 | -$11,099 | -$4,428 | $2,267 |
| Other Non-Cash | $8,661 | $15,227 | $14,789 | $5,187 |
| Operating Cash Flow | -$29,384 | -$33,242 | -$33,104 | -$34,970 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$16 | $0 | -$77 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $247 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$215 | $0 | -$1,598 | -$247 |
| Investing Cash Flow | -$231 | $0 | -$1,675 | -$6 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$100 | -$100 | $3,875 | $9,053 |
| Stock Issued | $31,910 | $32,100 | $20,462 | $33,578 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$608 | $2,227 | -$1,156 | $1,306 |
| Financing Cash Flow | $31,202 | $34,227 | $23,181 | $43,937 |
| Forex Effect | -$54 | $15 | $16 | $0 |
| Net Chg. in Cash | $1,533 | $1,000 | -$11,582 | $8,961 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,469 | $5,469 | $17,051 | $8,090 |
| End Cash | $8,002 | $6,469 | $5,469 | $17,051 |
| Free Cash Flow | -$29,615 | -$33,242 | -$34,779 | -$34,976 |